Does METHYLDOPA Cause Off label use? 152 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Off label use have been filed in association with METHYLDOPA (Methyldopa). This represents 5.8% of all adverse event reports for METHYLDOPA.
152
Reports of Off label use with METHYLDOPA
5.8%
of all METHYLDOPA reports
1
Deaths
58
Hospitalizations
How Dangerous Is Off label use From METHYLDOPA?
Of the 152 reports, 1 (0.7%) resulted in death, 58 (38.2%) required hospitalization, and 14 (9.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLDOPA. However, 152 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLDOPA Cause?
Foetal exposure during pregnancy (1,028)
Premature baby (792)
Maternal exposure during pregnancy (623)
Premature delivery (519)
Exposure during pregnancy (502)
Low birth weight baby (350)
Foetal growth restriction (172)
Drug ineffective (162)
Live birth (153)
Pre-eclampsia (110)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which METHYLDOPA Alternatives Have Lower Off label use Risk?
METHYLDOPA vs METHYLENE BLUE
METHYLDOPA vs METHYLENEDIOXYPYROVALERONE
METHYLDOPA vs METHYLERGONOVINE
METHYLDOPA vs METHYLNALTREXONE
METHYLDOPA vs METHYLPHENIDATE